These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


377 related items for PubMed ID: 11812999

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ, Jung JK, Lee SY, Jang KL.
    Cancer Lett; 2010 Feb 28; 288(2):226-35. PubMed ID: 19656618
    [Abstract] [Full Text] [Related]

  • 23. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.
    Passegué E, Wagner EF.
    EMBO J; 2000 Jun 15; 19(12):2969-79. PubMed ID: 10856241
    [Abstract] [Full Text] [Related]

  • 24. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.
    Nat Cell Biol; 2007 May 15; 9(5):493-505. PubMed ID: 17450133
    [Abstract] [Full Text] [Related]

  • 25. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 15; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 26. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence.
    Zhu D, Xu G, Ghandhi S, Hubbard K.
    J Cell Physiol; 2002 Oct 15; 193(1):19-25. PubMed ID: 12209876
    [Abstract] [Full Text] [Related]

  • 27. Upregulation of chicken p15INK4b at senescence and in the developing brain.
    Kim SH, Rowe J, Fujii H, Jones R, Schmierer B, Kong BW, Kuchler K, Foster D, Ish-Horowicz D, Peters G.
    J Cell Sci; 2006 Jun 15; 119(Pt 12):2435-43. PubMed ID: 16720639
    [Abstract] [Full Text] [Related]

  • 28. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
    Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W, Peters G.
    EMBO J; 2002 Jun 17; 21(12):2936-45. PubMed ID: 12065407
    [Abstract] [Full Text] [Related]

  • 29. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS, Wiman KG.
    Oncogene; 2003 Aug 07; 22(32):4993-5005. PubMed ID: 12902982
    [Abstract] [Full Text] [Related]

  • 30. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 31. PPP1CA contributes to the senescence program induced by oncogenic Ras.
    Castro ME, Ferrer I, Cascón A, Guijarro MV, Lleonart M, Ramón y Cajal S, Leal JF, Robledo M, Carnero A.
    Carcinogenesis; 2008 Mar 20; 29(3):491-9. PubMed ID: 18204081
    [Abstract] [Full Text] [Related]

  • 32. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts.
    Wei S, Wei S, Sedivy JM.
    Cancer Res; 1999 Apr 01; 59(7):1539-43. PubMed ID: 10197626
    [Abstract] [Full Text] [Related]

  • 33. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL, Weaks RL, Berton TR, Johnson DG.
    Oncogene; 2006 Feb 09; 25(6):867-76. PubMed ID: 16205640
    [Abstract] [Full Text] [Related]

  • 34. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
    Milyavsky M, Shats I, Erez N, Tang X, Senderovich S, Meerson A, Tabach Y, Goldfinger N, Ginsberg D, Harris CC, Rotter V.
    Cancer Res; 2003 Nov 01; 63(21):7147-57. PubMed ID: 14612508
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.